Hosting

Host is a biotechnology company launched by Flagship Pioneering that focuses on the interface between the human host and the microbiome to develop novel therapeutics. The company leverages a proprietary platform to identify and modulate host-pathogen interactions, aiming to treat infectious, inflammatory, and autoimmune diseases. By understanding how the host immune system responds to microbial signals, Host develops precision medicines that can either enhance or suppress specific biological pathways. The company's approach represents a shift from traditional pathogen-focused treatments to host-centric therapies that improve resilience and immune function.